Benjamin Derman

39PUBLICATIONS
150CO-AUTHORS
Medical mycologyGene and molecular therapyLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 23, 2026
Prognostic Significance of Cell-Free DNA Derived 5-Hydroxymethylcytosine Signatures in Newly Diagnosed Multiple Myeloma.

|May 27, 2026
Efficacy and safety of durcabtagene autoleucel in a phase 1 trial for patients with relapsed/refractory multiple myeloma.

|May 20, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.

|Apr 28, 2026
Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.

|Apr 10, 2026
Remote Therapeutic Monitoring and Infection-Related Health Care Resource Utilization in Patients With Hematologic Malignancies.

Benjamin A Derman, James H Essell, Mustafa S Ascha

|Jan 21, 2026
Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy bb21217 for Relapsed and Refractory Multiple Myeloma: Results from the Phase I CRB-402 Study.

Melissa Alsina, Nina Shah, Sundar Jagannath

Pageof 7

Frequent Collaborators

10 joint publications

Andrzej Jakubowiak

4 joint publications

Tadeusz Kubicki

4 joint publications

Andrew T Stefka

4 joint publications

Shaji Kumar